Syneron Candela Achieves Approval to Market Its ALEX II System in Japan For Treatment of Benign Dermal Lesions

[PR Newswire] – TOKYO, April 28, 2014 /PRNewswire/ — Syneron Medical Ltd. (ELOS), a leading global aesthetic device company, announced today that that its subsidiary in Japan, Candela KK, received registration approval from the Japanese Ministry of Heal more

View todays social media effects on ELOS

View the latest stocks trending across Twitter. Click to view dashboard

See who Syneron is hiring next, click here to view